Categories Earnings, LATEST, Other Industries

Stryker confirms that it didn’t bid for Boston Scientific

Two days after the acquisition speculation sparked in the internet, medical equipment maker Stryker (SYK) stated today in an 8-K filing that it is “not in discussions with Boston Scientific Corporation (BSX) regarding a potential acquisition.”

On June 11, WSJ had reported that Stryker had offered to buy Boston Scientific, which made the latter’s shares shoot to its 52-week new high. On contrary, Stryker ended in red on Monday. Trading of both the companies’ shares was stopped for a while because of high volatility.

Related: Boston Scientific spikes to new 52-week high on takeover rumors

Earlier, both Stryker and Boston Scientific abstained from commenting on the deal. But today the Kalamazoo, Michigan-based medical tech company has confirmed officially that it is not interested in buying Boston Scientific. There are also rumors going around that Johnson & Johnson (JNJ) might bid on the Marlborough, Massachusetts-based company.

Considered one of the megadeals if happened, this acquisition would have created a combined company that would have had revenue of $25 billion in 2019, according to RBC analyst Glenn Novarro.

On Stryker’s confirmation that the deal was not happening, the company’s shares rose about 7% and Boston Scientific stock dropped around 7% during pre-market trading today. When the market opened up, Stryker and Boston Scientific continued the same trend.

Most Popular

Important takeaways from Paychex’s (PAYX) Q2 2025 earnings report

Paychex Inc. (NASDAQ: PAYX), a leading provider of human resources and payroll services, reported better-than-expected revenue and profit for the second quarter of fiscal 2025, sending the stock higher soon

Lamb Weston’s (LW) challenges may not end soon, a few points to note

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) turned red in mid-day trade on Friday. The stock has dropped 19% in the past one month. The company delivered disappointing results

CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%

Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss

Comments

Comments are closed.

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top